D. E. V. Wilman

721 citations

33 papers · 611 · h-index 13

Impact in

Physical and Theoretical Chemistry top 5%
- Chemical Reactions and Mechanisms
Organic Chemistry top 10%
- Chemical Reaction Mechanisms
- Click Chemistry and Applications
- Synthesis and Biological Evaluation
- Synthesis and Characterization of Heterocyclic Compounds

Papers in

Organic Chemistry 21
- Synthesis and Characterization of Heterocyclic Compounds 8
- Click Chemistry and Applications 4
- Chemical Reaction Mechanisms 4
- Synthesis and Reactions of Organic Compounds 4
- Synthesis and Biological Evaluation 4
- Structural and Chemical Analysis of Organic and Inorganic Compounds 3
Physical and Theoretical Chemistry 10
- Chemical Reactions and Mechanisms 10

Co-authors: Phyllis M. Goddard (4 shared papers)T.A. Connors (4 shared papers)P.D. Lawley (1 shared paper)Martin R. Osborne (1 shared paper)W. C. J. Ross (3 shared papers)Richard T. Wheelhouse (3 shared papers)Malcolm F. G. Stevens (3 shared papers)Michael Jarman (2 shared papers)
Journals: Journal of Medicinal Chemistry (5 papers)Acta Crystallographica Section C Crystal Structure Communications (4 papers)Biochemical Pharmacology (3 papers)Magnetic Resonance in Chemistry (2 papers)NMR in Biomedicine (1 paper)
Partner nations: United Kingdom Canada United States

In The Last Decade

D. E. V. Wilman

32 papers receiving 560 citations

Peers

Countries citing papers authored by D. E. V. Wilman

Since Specialization

Citations

This map shows the geographic impact of D. E. V. Wilman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. E. V. Wilman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. E. V. Wilman more than expected).

Fields of papers citing papers by D. E. V. Wilman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. E. V. Wilman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. E. V. Wilman. The network helps show where D. E. V. Wilman may publish in the future.

Co-authors

The 25 scholars most cited alongside D. E. V. Wilman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. E. V. Wilman Line = papers co-authored together D. E. V. Wilman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Tumour inhibitory triazenes: Structural requirements for an active metabolite Biochemical Pharmacology ·T.A. Connors, Phyllis M. Goddard, Kanti Merai, W. C. J. Ross, D. E. V. Wilman	1976	104
2	Alkylation of DNA by the Nitrogen Mustard Bis-(2-chloroethyl)methylamine Chemical Research in Toxicology ·Martin R. Osborne, D. E. V. Wilman, P.D. Lawley	1995	81
3	The Chemistry of Antitumour Agents D. E. V. Wilman	1990	63
4	Phospholipid metabolites, prognosis and proliferation in human breast carcinoma NMR in Biomedicine ·Timothy Smith, C. Bush, Charles Jameson, Jenny Titley, Martin O. Leach, D. E. V. Wilman, V. R. McCready	1993	42
5	Gas chromatographic analysis of triethylenethiophosphoramide and triethylenephosphoramide in biological specimens Journal of Chromatography B Biomedical Sciences and Applications ·Barbara J. McDermott, J A Double, M.C. Bibby, D. E. V. Wilman, Paul M. Loadman, Robert L. Turner	1985	27
6	Cytotoxic Agents Designed To Be Selective for Liver Cancer2 JNCI Journal of the National Cancer Institute ·Agussalim Bukhari, T.A. Connors, Aedin M. Gilsenan, W. C. J. Ross, M J Tisdale, G. P. Warwick, D. E. V. Wilman	1973	26
7	Synthesis and cytotoxicity of potential tumor-inhibitory analogs of trimelamol (2,4,6-tris[(hydroxymethyl)methylamino]-1,3,5-triazine) having electron-withdrawing groups in place of methyl Journal of Medicinal Chemistry ·Michael Jarman, Helen M. Coley, Ian Judson, Timothy J. Thornton, D. E. V. Wilman, G Abel, C.J. Rutty	1993	25
8	Analogs of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents Journal of Medicinal Chemistry ·Chui Sheung Leung, Martin Rowlands, Michael Jarman, A. B. Foster, Leslie J. Griggs, D. E. V. Wilman	1987	25
9	Prodrugs in cancer chemotherapy Biochemical Society Transactions ·D. E. V. Wilman	1986	22
10	Comparison of half-lives and cytotoxicity of N-chloroethyl-4-amino and N-mesyloxyethyl-benzoyl compounds, products of prodrugs in antibody-directed enzyme prodrug therapy (ADEPT). PubMed ·Caroline J. Springer, Pari Antoniw, K D Bagshawe, D. E. V. Wilman	1991	20
11	Antitumour imidazotetrazines. Part 31. The synthesis of isotopically labelled temozolomide and a multinuclear (1H, 13C, 15N) magnetic resonance investigation of temozolomide and mitozolomide Journal of the Chemical Society Perkin Transactions 1 ·Richard T. Wheelhouse, D. E. V. Wilman, William Thomson, Malcolm F. G. Stevens	1995	18
12	A ¹⁵N NMR investigation of a series of benzotriazinones and related antitumour heterocycles Magnetic Resonance in Chemistry ·Keith Vaughan, D. E. V. Wilman, Richard T. Wheelhouse, Malcolm F. G. Stevens	2002	16
13	Phase I trial and pharmacokinetics of trimelamol (N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine). PubMed ·Ian Judson, A H Calvert, C.J. Rutty, G. Abel, Lindsey Gumbrell, Marien Alet Graham, B D Evans, D. E. V. Wilman, S. Ashley, F. Cairnduff	1989	12
14	Tumor inhibitory triazenes. 3. Dealkylation within an homologous series and its relation to antitumor activity Journal of Medicinal Chemistry ·D. E. V. Wilman, Peter J. Cox, Phyllis M. Goddard, Leigh I. Hart, Kanti Merai, David R. Newell	1984	12
15	Cytotoxic sulphonamides designed for selective deposition in malignant tissue European Journal of Cancer (1965) ·G Abel, T.A. Connors, Phyllis M. Goddard, H. Hoellinger, Nguyen‐Hoang‐Nam, L. Pichat, W. C. J. Ross, D. E. V. Wilman	1975	11
16	Tumour inhibitory triazenes. 5—¹⁵N NMR study of 1‐aryl‐3,3‐dialkyltriazenes Magnetic Resonance in Chemistry ·D. E. V. Wilman	1990	11
17	Tumor inhibitory triazenes. 2. Variation of antitumor activity within an homologous series Journal of Medicinal Chemistry ·D. E. V. Wilman, Phyllis M. Goddard	1980	11
18	The development of a second-generation triazene Cancer Treatment Reviews ·D. E. V. Wilman	1988	10
19	X-ray studies on anti-tumour triazenes. Structures of 1-(4-carbamoylphenyl)-3,3-dimethyltriazene 1-oxide and 3,3-dimethyl-1-(4-nitrophenyl)triazene Acta Crystallographica Section B Structural Science ·Stephen Neidle, D. E. V. Wilman	1992	10
20	Enzyme activated anti-tumour agents—III. hydrolysis of conjugates of p-hydroxyaniline mustard in aqueous solution Biochemical Pharmacology ·Paul Workman, John A. Double, D. E. V. Wilman	1976	9

About D. E. V. Wilman

D. E. V. Wilman is a scholar working on Organic Chemistry, Physical and Theoretical Chemistry, Molecular Biology, Oncology and Pharmaceutical Science, having authored 33 papers that have together received 611 indexed citations. Recurring topics across this work include Chemical Reactions and Mechanisms (10 papers), Synthesis and Characterization of Heterocyclic Compounds (8 papers), Click Chemistry and Applications (4 papers), Chemical Reaction Mechanisms (4 papers), Chemical Reactions and Isotopes (4 papers), Synthesis and Reactions of Organic Compounds (4 papers), Synthesis and Biological Evaluation (4 papers) and Structural and Chemical Analysis of Organic and Inorganic Compounds (3 papers). The work is most often cited by research in Physical and Theoretical Chemistry (115 citations), Organic Chemistry (269 citations), Pharmaceutical Science (46 citations), Toxicology (16 citations) and Pharmacology (38 citations). D. E. V. Wilman has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Phyllis M. Goddard, T.A. Connors, P.D. Lawley, Martin R. Osborne, W. C. J. Ross, Richard T. Wheelhouse, Malcolm F. G. Stevens, Michael Jarman, Keith Vaughan and Martin O. Leach. Their work appears in journals such as Journal of Medicinal Chemistry, Acta Crystallographica Section C Crystal Structure Communications, Biochemical Pharmacology, Magnetic Resonance in Chemistry and NMR in Biomedicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

D. E. V. Wilman

Impact in

Papers in i

In The Last Decade

D. E. V. Wilman

Peers

Countries citing papers authored by D. E. V. Wilman

Fields of papers citing papers by D. E. V. Wilman

All Works

About D. E. V. Wilman

Explore authors with similar magnitude of impact

Papers in